Healthy Eating in Women at Risk of Gestational Diabetes
SAGE
Promoting Healthy Eating in Early Pregnancy in Women at Risk of Gestational Diabetes Mellitus: Does it Improve Glucose Homeostasis?
1 other identifier
interventional
150
1 country
1
Brief Summary
Healthy eating during pregnancy has favorable effects on markers related to diabetes (glucose tolerance) and is associated with lower gestational diabetes mellitus (GDM) risk. The cornerstone of GDM treatment is nutrition therapy but the latter often starts late in pregnancy and thus may not have the expected effects on glucose tolerance. What if an intervention promoting healthy eating was initiated at the beginning of pregnancy in all women at risk, would it improve glucose homeostasis? To answer this important question, the investigators will perform a randomized controlled trial in 150 pregnant women. Women receiving the nutritional intervention will be compared to a control group receiving standard care. The nutritional intervention, which will start in the first trimester, is based on the 2019 Canada's Food Guide and is composed of 4 individual sessions with a registered dietitian (12, 18, 24 and 30 weeks). Between those follow-ups, informative nutritional web capsules and phone calls with the registered dietitian will be provided. To ensure that the women remain motivated and receive social support, a private Facebook group will be used. The investigators hypothesize that the nutritional intervention will be effective at improving glucose homeostasis. The investigators expect the results will show the importance of nutritional care starting early in pregnancy in women at risk of GDM.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2022
CompletedFirst Posted
Study publicly available on registry
March 29, 2022
CompletedStudy Start
First participant enrolled
June 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
ExpectedSeptember 9, 2025
September 1, 2025
3.6 years
February 28, 2022
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fasting plasma glucose
Measured after a 12-hour fast.
Changes from the 1st to the 3rd trimester
Secondary Outcomes (6)
Post-prandial plasma glucose
Changes from the 1st to the 3rd trimester
Glycemic response
Changes from the 1st to the 3rd trimester
Hepatic insulin sensitivity
Changes from the 1st to the 3rd trimester
Hepatic and peripheral insulin sensitivity index
Changes from the 1st to the 3rd trimester
Beta-cell function index
Changes from the 1st to the 3rd trimester
- +1 more secondary outcomes
Study Arms (2)
Nutritional Intervention
EXPERIMENTALIntervention promoting healthy eating by a Registered Dietitian.
Standard Care
NO INTERVENTIONWomen will have their usual medical pregnancy follow-ups by their MDs without access to nutritional care.
Interventions
4 individual 1-hour in person (or virtual, according to potential public health restrictions and patients' preference) motivational interviews (12, 18, 24 and 30 weeks) with a registered dietitian will be conducted to elaborate S.M.A.R.T. (Specific,Measurable, Attainable, Relevant, Timely) goals regarding diet, based on the 2019 Canada's Food Guide. Between those individual follow-ups, 4 phone calls with the registered dietitian will be provided (15, 21, 27, 33 weeks). Throughout the study, 10 informative nutritional video clips will also be provided. Participants receiving the intervention will have access to an online Facebook private community to discuss and share experiences, thus maintaining motivation and providing social support.
Eligibility Criteria
You may qualify if:
- ≤ 14 gestational weeks;
- Singleton pregnancy;
- At risk of GDM According to Diabetes Canada (being 35 years of age or older or from a high-risk group (African, Arab, Asian, Hispanic, Indigenous, or South Asian) or having a BMI ≥ 30 kg/m2, prediabetes, GDM in a previous pregnancy, given birth to a baby that weighed more than 4 kg, a parent, brother or sister with type 2 diabetes, polycystic ovary syndrome or acanthosis nigricans (darkened patches of skin).
You may not qualify if:
- Having a diabetes diagnosis in the 1st trimester;
- Pre-existing diabetes mellitus;
- Diseases requiring active nutritional treatment or influencing glucose metabolism (including previous bariatric surgery);
- Taking part in a nutritional intervention program;
- Corticosteroid use;
- Previous or current diagnosis of an eating disorder;
- Inability to give informed consent;
- Inability to communicate in French.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Quebec-Universite Lavallead
- Canadian Institutes of Health Research (CIHR)collaborator
- Laval Universitycollaborator
Study Sites (1)
CHU de Québec-Université Laval
Québec, Quebec, G1V 4G2, Canada
Related Publications (1)
Bernier E, Plante AS, Lemieux P, Robitaille J, Lemieux S, Desroches S, Belanger-Gravel A, Maheux-Lacroix S, Weisnagel SJ, Demers S, Camirand Lemyre F, Boulet M, Baillargeon JP, Morisset AS. Promoting healthy eating in early pregnancy in individuals at risk of gestational diabetes mellitus: does it improve glucose homeostasis? A study protocol for a randomized control trial. Front Nutr. 2024 Jan 19;10:1336509. doi: 10.3389/fnut.2023.1336509. eCollection 2023.
PMID: 38312142DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anne-Sophie Morisset, RD, PhD
CHU de Québec-Université Laval
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 28, 2022
First Posted
March 29, 2022
Study Start
June 30, 2022
Primary Completion
February 1, 2026
Study Completion (Estimated)
February 1, 2027
Last Updated
September 9, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share